CDKN2A and hepatocellular carcinoma: In the prognostic classification model, BMI1 is a member of the polycomb protein family, acts as an oncogene in the carcinogenesis of hepatocellular carcinoma in an independent manner of INK4a/ARF loci, and has been proved to be a qualified therapeutic target for HCC [35].